{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:29:45Z","timestamp":1792099785689,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152646","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:49:38Z","timestamp":1758055778000},"page":"152646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["OGT-mediated O-GlcNAcylation of OR51F2 protein aggravates the malignant phenotypes of prostate cancer cells"],"prefix":"10.1016","volume":"784","author":[{"given":"Siyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152646_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/1073274819855118","article-title":"Comprehensive analysis reveals a 4-Gene signature in predicting response to temozolomide in low-grade glioma patients","volume":"26","author":"Wang","year":"2019","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbrc.2025.152646_bib2","article-title":"Altered glycosylation in cancer: a promising target for biomarkers and therapeutics","volume":"1875","author":"Thomas","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2025.152646_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1172\/JCI63146","article-title":"Increased sugar uptake promotes oncogenesis via EPAC\/RAP1 and O-GlcNAc pathways","volume":"124","author":"Onodera","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152646_bib4","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/s41388-021-01901-7","article-title":"OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.152646_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12033-024-01049-1","article-title":"O-GlcNAcylation of CSNK2A1 by OGT is involved in the progression of colorectal cancer","volume":"67","author":"Yu","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152646_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41418-021-00901-0","article-title":"O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-\u03b2 signaling to breast cancer progression","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2025.152646_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/1541-7786.MCR-21-0477","article-title":"VPRBP functions downstream of the androgen receptor and OGT to restrict p53 activation in prostate cancer","volume":"20","author":"Poulose","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152646_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5534\/wjmh.220231","article-title":"OGT and FLAD1 genes had significant prognostic roles in progressive pathogenesis in prostate cancer","volume":"41","author":"Kim","year":"2023","journal-title":"World J. Mens Health"},{"key":"10.1016\/j.bbrc.2025.152646_bib9","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.celrep.2018.11.042","article-title":"ULK1 O-GlcNAcylation is crucial for activating VPS34 via ATG14L during autophagy initiation","volume":"25","author":"Pyo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2025.152646_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fendo.2013.00099","article-title":"O-GlcNAcylation: a new cancer hallmark?","volume":"4","author":"Fardini","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152646_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/mmr.2014.2269","article-title":"O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells","volume":"10","author":"Gu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2025.152646_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216258","article-title":"O-GlcNAcylation in cancer development and immunotherapy","volume":"566","author":"He","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.152646_bib13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbagen.2019.04.002","article-title":"Essential role of O-GlcNAcylation in stabilization of oncogenic factors","volume":"1863","author":"Makwana","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbrc.2025.152646_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-020-1110-9","article-title":"Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p\/OGT axis","volume":"20","author":"Zheng","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2025.152646_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41419-020-02999-5","article-title":"Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion","volume":"11","author":"Seo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2025.152646_bib16","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/jcmm.14043","article-title":"O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E","volume":"23","author":"Cao","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152646_bib17","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/1541-7786.MCR-20-0339","article-title":"Inhibition of O-GlcNAc transferase renders prostate cancer cells dependent on CDK9","volume":"18","author":"Itkonen","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152646_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s11658-020-00208-x","article-title":"Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells","volume":"25","author":"Jin","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbrc.2025.152646_bib19","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.7150\/thno.30834","article-title":"High OGT activity is essential for MYC-driven proliferation of prostate cancer cells","volume":"9","author":"Itkonen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2025.152646_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109739","article-title":"DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation","volume":"36","author":"Song","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2025.152646_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110718","article-title":"O-GlcNAcylation enhances Reticulon 2 protein stability and its promotive effects on gastric cancer progression","volume":"108","author":"Wang","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2025.152646_bib22","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/liv.14904","article-title":"The crosstalk network of XIST\/miR-424-5p\/OGT mediates RAF1 glycosylation and participates in the progression of liver cancer","volume":"41","author":"Ning","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2025.152646_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108148","article-title":"OGT\/HIF-2\u03b1 axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2025.152646_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/1120009X.2022.2102303","article-title":"Luteolin suppresses lung cancer progression through targeting the circ_0000190\/miR-130a-3p\/notch-1 signaling pathway","volume":"35","author":"Zheng","year":"2023","journal-title":"J. Chemother."},{"key":"10.1016\/j.bbrc.2025.152646_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-021-01935-5","article-title":"ROC1 promotes the malignant progression of bladder cancer by regulating p-I\u03baB\u03b1\/NF-\u03baB signaling","volume":"40","author":"Wu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152646_bib26","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1002\/cam4.5550","article-title":"LncRNA DICER1-AS1 promotes colorectal cancer progression by activating the MAPK\/ERK signaling pathway through sponging miR-650","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2025.152646_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:30:47Z","timestamp":1780302647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25013622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"alternative-id":["S0006291X25013622"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152646","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OGT-mediated O-GlcNAcylation of OR51F2 protein aggravates the malignant phenotypes of prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152646"}}